Guidelines for Management of Cardiovascular Disease and Risk Factors

Guideline Organization

Sub-topic

CARI-Australia

CKD Guideline-CV Risk Factors2005

• Lipid Lowering Therapy

CKD Guideline-Prevention of Progression of Kidney Disease2006

CKD Guideline-Prevention of Progression of Kidney Disease

• Antihypertensive therapy in diabetic nephropathy
• ACE inhibitor treatment in diabetic nephropathy
• Angiotensin II antagonists 
• ACE inhibitor and angiotensin II antagonist combination treatment
• Blood pressure control: targets
• Blood pressure control: role of specific anti-hypertensives

CSN-Canada

Chapter 2: Management of Blood Pressure in HD Patients 2006

Management of Blood Pressure in HD Patients (Chapter2)

• Blood Pressure Measurement-Timing and Targets (PDF Page 8 of 27)
• Management of Hypertension (PDF Page 8 of 27)

EBPG-Europe

Guidelines on Hemodialysis (Part 2)
2007

EBPG guideline on haemodynamic instability

• Evaluation of the patient 
• Lifestyle interventions 
• Factors relation to the dialysis treatment
• Antihypertensive drugs and preventive medication
• Stratified approach to prevent IDH
• Treatment of IDH

KDOQI-US

Managing Dyslipidemias in Chronic Kidney Disease
2006 Updates

Assessment of Dyslipidemias

• Guideline 1.
• Guideline 2.
• Guideline 3.

Treating Dyslipidemias

• Guideline 4.
• Guideline 5.

Research Recommendations

Hypertension and Antihypertensive Agents in Chronic Kidney Disease

Hypertension and Antihypertensive Agents in Chronic Kidney Disease

• Goals of Antihypertensive Therapy in CKD
• Evaluation of Patients With CKD or Hypertension
• Measurement of Blood Pressure in Adults
• Evaluation for Renal Artery Disease
• Education on Self-Management Behavior
• Dietary and Other Therapeutic Lifestyle Changes in Adults
• Pharmacological Therapy: Use of Antihypertensive Agents in CKD
• Pharmacological Therapy: Diabetic Kidney Disease
• Pharmacological Therapy: Nondiabetic Kidney Disease
• Pharmacological Therapy: Kidney Disease in the Kidney Transplant Recipient
• Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in CKD
• Use of Diuretics in CKD
• Special Considerations in Children
• Recommendations for Clinical Performance Measures

Cardiovascular Disease in Dialysis Patients
2005

Guidelines on evaluation and management of cardiovascular diseases

• Evaluation of Cardiovascular Disease in Adult and Pediatric Patients
• Coronary Artery Disease
• Acute Coronary Syndromes
• Chronic Coronary Artery Disease
• Valvular Heart Disease
• Cardiomyopathy (Systolic or Diastolic Dysfunction)
• Dysrhythmia
• External Defibrillation
• Cerebrovascular Disease
• Peripheral Vascular Disease

Guidelines on management of cardiovascular risk factors

• Diabetes
• Blood Pressure
• Dyslipidemia
• Smoking, Physical Activity, and Psychological Factors
• Anemia
• Arterial Stiffness, Vascular and Valvular Calcification, Calcium, Phosphorus and PTH

State of the science: novel and controversial topics in cardiovascular diseases
Intradialytic Hypotension
Biomarkers
Troponin
Inflammation
Oxidative Stress
Nutritional and Metabolic Factors
Body Weight and Management
Omega-3 Fatty Acids
Homocysteine
Lipoprotein(a) and Apolipoprotein(a) Polymorphism
Malnutrition
Risk Stratification
Overview of Risk Stratification
Family History and Genetics
Menopause
Preventive Foot Care in Diabetes
Aspirin

UK-Renal Association

Module 2:
Complication of CKD - Section 1
2007

Management of Cardiovascular disease

• Cardiovascular risk factors
• Smoking and exercise
• HBA1C
• Hypercholesterolaemia
• Hyperhomocysteinaemia and folate supplementation
• Secondary prevention of cardiovascular risk
• Cardiac investigations and coronary revascularization
• Hypertension: Chronic Kidney Disease on renal replacement therapy